Publikation

Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)

Wissenschaftlicher Artikel/Review - 01.02.2005